Paper666302
Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
Neu HC and 1 other. Antimicrob Agents Chemother, 1978. Cited by 75 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins. Papers, record 666302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/666302
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Cephalosporins | Major topic |
| Penicillins | Major topic |
| Aminoglycosides | |
| Drug Synergism | |
| Enterobacteriaceae | |
| Microbial Sensitivity Tests | |
| Pseudomonas |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 190,540 | The nephrotoxicity of antimicrobial agents (second of three parts). | N Engl J Med | 1977 | https://conductscience.org/library/papers/190540 | PubMed |
| 2 | 402,574 | The nephrotoxicity of antimicrobial agents (first of three parts). | N Engl J Med | 1977 | https://conductscience.org/library/papers/402574 | PubMed |
| 3 | 320,483 | The nephrotoxicity of antimicrobial agents (third of three parts). | N Engl J Med | 1977 | https://conductscience.org/library/papers/320483 | PubMed |
| 4 | 825,582 | Ticarcillin for treatment of serious infections with gram-negative bacteria. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825582 | PubMed |
| 5 | 1,041,717 | Antibacterial activity of combinations of cefazolin and semisynthetic penicillins. | J Antibiot (Tokyo) | 1975 | https://conductscience.org/library/papers/1041717 | PubMed |
| 6 | 984,795 | Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984795 | PubMed |
| 7 | 4,994,878 | Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. | N Engl J Med | 1971 | https://conductscience.org/library/papers/4994878 | PubMed |
| 8 | 808,545 | The formation of functional penicillin-binding proteins. | J Biol Chem | 1975 | https://conductscience.org/library/papers/808545 | PubMed |
| 9 | 1,102,266 | Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. | Chemotherapy | 1975 | https://conductscience.org/library/papers/1102266 | PubMed |
| 10 | 791,104 | In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/791104 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,370,312 | Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in blaCTX-M-1 Encoding Escherichia coli. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37370312 | PubMed |
| 34,230,527 | A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms. | Sci Rep | 2021 | https://conductscience.org/library/papers/34230527 | PubMed |
| 33,268,776 | A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. | NPJ Biofilms Microbiomes | 2020 | https://conductscience.org/library/papers/33268776 | PubMed |
| 29,058,043 | Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria. | Curr Microbiol | 2018 | https://conductscience.org/library/papers/29058043 | PubMed |
| 7,095,864 | [Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)]. | Infection | 1982 | https://conductscience.org/library/papers/7095864 | PubMed |
| 6,982,681 | Antibacterial activity and beta-lactamase stability of temocillin. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6982681 | PubMed |
| 6,981,375 | In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6981375 | PubMed |
| 6,454,388 | In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6454388 | PubMed |
| 6,447,474 | Mezlocillin for treatment of infections in cancer patients. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6447474 | PubMed |
| 6,435,516 | In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6435516 | PubMed |
| 6,423,179 | Combinations of beta lactam antibiotics. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6423179 | PubMed |
| 6,315,425 | Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin. | Eur J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6315425 | PubMed |
| 6,255,862 | Synergistic activity of piperacillin in combination with beta-lactamase inhibitors. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6255862 | PubMed |
| 6,218,105 | [Mezlocillin in neonatal medicine]. | Infection | 1982 | https://conductscience.org/library/papers/6218105 | PubMed |
| 6,217,066 | Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin. | Eur J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6217066 | PubMed |
| 6,214,995 | In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6214995 | PubMed |
| 6,100,427 | In vitro activity and beta-lactamase stability of cefmenoxime. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6100427 | PubMed |
| 3,634,545 | Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas. | Yale J Biol Med | 1986 | https://conductscience.org/library/papers/3634545 | PubMed |
| 3,069,193 | Antibiotic combinations: should they be tested? | Clin Microbiol Rev | 1988 | https://conductscience.org/library/papers/3069193 | PubMed |
| 2,938,945 | Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/2938945 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/666302
GET https://conductscience.org/api/papers/v1/666302/cited_by?page=2